Understand the autoimmune partnering landscape using intelligence from 1,066 real-world collaboration and licensing deals.
Autoimmune Collaboration and Licensing Deals 2016-2026 provides comprehensive intelligence on 1,066 partnering deals involving autoimmune assets, technologies and development programs.
Autoimmune disease represents a broad and active area of life sciences partnering, encompassing multiple therapeutic targets, development stages, technologies and deal structures.
The report brings this activity together in one resource, enabling users to understand who is partnering, what is attracting deal activity, how transactions are structured, what financial terms have been disclosed and how partnering activity differs across autoimmune targets and technologies.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with detailed financial benchmarking, leading dealmaker intelligence, individual transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, corporate strategy, R&D strategy, competitive intelligence and legal teams involved in autoimmune partnering.
Understand the autoimmune partnering landscape
The report analyzes autoimmune dealmaking from 2016 to 2026, including:
- Trends in autoimmune partnering activity by year
- Deal activity by deal type
- Industry sector
- Stage of development at the time of partnering
- Technology type
- Autoimmune therapeutic target
- Most active autoimmune dealmakers
- Leading deals by disclosed value
- How autoimmune partnering activity is evolving
This enables users to understand where activity is concentrated and identify the companies, technologies, development stages and therapeutic targets attracting partnering interest.
Benchmark autoimmune deal financials
The economics of autoimmune deals can vary significantly according to the asset, development stage, technology, rights granted and overall structure of the transaction.
The report provides dedicated analysis of disclosed financial terms, including:
- Headline deal values
- Upfront payments
- Milestone payments
- Royalty rates
Individual transactions can then be investigated in greater depth to understand the context behind the disclosed economics.
This provides users with real-world reference points when preparing internal benchmarks, evaluating opportunities or entering partnering discussions.
Financial benchmarks are most valuable when considered alongside the structure and circumstances of comparable deals rather than as standalone averages, and the report provides the wider transaction intelligence needed to establish that context.
Identify leading autoimmune dealmakers and prospective partners
The report identifies the most active companies in autoimmune dealmaking and provides extensive transaction histories that enable users to investigate their partnering activity.
This can help users identify:
- Companies actively seeking autoimmune opportunities
- Potential licensing and collaboration partners
- Organizations repeatedly partnering in particular therapeutic areas
- Companies active at relevant stages of development
- Dealmakers showing interest in specific technologies or approaches
- Competitors pursuing similar external innovation strategies
For companies seeking to partner an autoimmune asset or technology, previous deal activity can provide valuable evidence of which organizations have demonstrated a genuine appetite for comparable opportunities.
Compare deals across therapeutic targets
Autoimmune is not a single homogeneous partnering market.
The report provides analysis by autoimmune therapeutic target, enabling users to investigate differences in partnering activity across individual areas of autoimmune disease and identify transactions most relevant to a particular program or strategic interest.
This helps users move beyond broad autoimmune benchmarks and focus on the subset of transactions most relevant to their own opportunity.
Understand how autoimmune agreements are structured
The report includes collaboration, licensing and other partnering transactions, enabling users to examine how companies have structured relationships around autoimmune assets and technologies.
Depending on the transaction and available disclosure, users can investigate areas including:
- Rights granted and retained
- Research and development responsibilities
- Licensing rights
- Exclusivity
- Geographic rights
- Intellectual property
- Development and regulatory responsibilities
- Commercialization rights
- Financial consideration
- Milestones and royalties
- Governance
- Term and termination provisions
These real-world examples provide useful reference points when considering the appropriate structure for a new autoimmune partnership.
Learn from real-world contract documents
Where publicly available, the report provides access to underlying contract documents for selected autoimmune transactions.
These agreements can reveal substantially more detail than headline announcements alone, helping users understand how companies have documented areas such as:
- Scope of rights
- Development obligations
- Intellectual property
- Exclusivity
- Financial terms
- Milestone triggers
- Royalty provisions
- Commercialization rights
- Termination and other negotiated provisions
For teams preparing or negotiating an autoimmune collaboration or licensing transaction, access to real agreement language provides valuable insight into how comparable deals have been structured in practice.
Comprehensive autoimmune deal directory
The report includes a comprehensive directory of 1,066 autoimmune collaboration and licensing deals, providing a detailed resource for identifying relevant precedent transactions.
Deals can be reviewed by:
- Company
- Technology type
- Therapeutic target
- Contract availability
Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
Who should use this report?
Business Development and Licensing teams
Identify comparable autoimmune transactions, prospective partners and relevant deal structures.
Search and Evaluation teams
Understand which companies are actively seeking opportunities across particular autoimmune targets, technologies and stages of development.
Biotechnology Companies Seeking Partners
Identify organizations with demonstrated interest in comparable autoimmune assets and technologies.
Corporate and R&D Strategy teams
Understand how competitors and potential partners are building autoimmune pipelines through external innovation.
Competitive and Market Intelligence teams
Track activity by company, development stage, technology and therapeutic target to understand evolving partnering priorities.
Legal and Transaction teams
Review publicly available contracts and precedent agreement structures to support transaction preparation and negotiation.
Turn market-wide autoimmune intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.
The briefing applies the underlying autoimmune deal intelligence to the customer's own asset, technology, target or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, deal structures, financial benchmarks, royalty analysis, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in autoimmune dealmaking
Chapter 3 - Financial deal terms for autoimmune deals
Chapter 4 - Leading autoimmune dealmakers and deals
Chapter 5 - Autoimmune deal contract document directory
Chapter 6 - Autoimmune dealmaking by therapeutic target
Deal Directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 2seventy bio
- 3Derm Systems
- 4D Pharma
- 4P-Pharma
- 4P Therapeutics
- 4SC
- 9 Meters Biopharma
- 10X Genomics
- AB Biosciences
- Abbott Laboratories
- Abbvie
- AbCellera Biologics
- Abreos Biosciences
- AbSci
- Ab Studio
- Abzena
- AC Bioscience
- Accelerated Cure Project for MS
- Accord Healthcare
- Accro Bioscience
- Acelyrin
- Acepodia
- Aclaris Therapeutics
- Acrobat Genomics
- Acrotech Biopharma
- Acucela
- Aculys Pharma
- AdAlta
- Adaptive Biotechnologies
- Adare Pharma Solutions
- Adhera Therapeutics
- Adicet Bio
- Adimune
- Adiso Therapeutics
- Aditum Bio
- Aduro BioTech
- Adynxx
- Aequus Pharmaceuticals
- AeroRx Therapeutics
- Aerpio Pharmaceuticals
- Aevi Genomic Medicine
- Affibody
- AffyXell Therapeutics
- AGC Biologics
- AgeX Therapeutics
- Agility Life Sciences
- AgomAb Therapeutics
- AHN Autoimmunity Institute
- AIMA Laboratories
- AirNexis Therapeutics
- Akaal Pharma
- Akebia Therapeutics
- Akouos
- Akston Biosciences
- Alba Therapeutics
- Alchemedicine
- Alex Therapeutics
- Alfasigma
- Alimentiv
- Alimera Sciences
- Alivio Therapeutics
- Alkermes
- Allakos
- Allegheny General Hospital
- Allegheny Technologies
- Allen Institute for Immunology
- Allergan
- Alliance for Lupus Research
- Allogene Therapeutics
- Alma Bio Therapeutics
- Almirall
- Alpha Cancer Technologies
- Alpine Immune Sciences
- AltaVoice
- ALTuCELL
- Alvit LCS Pharma
- Alvotech
- Amarex Clinical Research
- Amarna Therapeutics
- Ambiopharm
- Ambry Genetics
- Amegabiotech
- American College of Chest Physicians
- American Lung Association
- American National Multiple Sclerosis Society
- American Skin Association
- Amgen
- Amneal Pharmaceuticals
- AMPEL BioSolutions
- Amytrx Therapeutics
- AnaptysBio
- AnGes MG
- Animal Allergy Clinical Laboratories
- Anokion
- Antengene
- Anthem Bluecross
- Antibe Therapeutics
- AntibioTx
- Antidote
- AOBiome Therapeutics
- Applied Biology
- Applied BioMath
- Aptorum Group
- Aptuit
- Arbor Biotechnologies
- Arch Biopartners
- Arctic Vision
- Arcutis Biotherapeutics
- Arena Pharmaceuticals
- argenx
- Aristea Therapeutics
- Ark Biosciences
- Arrien Pharmaceuticals
- Arrowhead Pharmaceuticals
- Artisan Bio
- Artizan Biosciences
- Asahi Kasei
- Ascensia Diabetes Care
- ASKA Pharmaceuticals
- AskAt
- Aslan Pharma
- Aspect Biosystems
- Assembly Biosciences
- Astellas Pharma
- Asthma UK
- AstraZeneca
- Astria Therapeutics
- Atara Biotherapeutics
- Athos Therapeutics
- Attwill Medical Solutions
- ATUM
- aTyr Pharma
- Augurex Life Sciences
- Aurinia Pharmaceuticals
- Australasian Gastro Intestinal Research Foundation
- Autobahn Therapeutics
- Autolus
- Avacta
- Avadel Pharmaceuticals
- Avalere Health
- Avicanna
- AXIM Biotechnologies
- Axoltis Pharma
- Axsome Therapeutics
- Azenta Life Sciences
- Bachem
- Back-A-Line
- Basilea Pharmaceutica
- Bausch & Lomb
- Bausch Health Companies
- Baxalta
- Bayer
- Baylor Health Care System
- Bazelet
- BCD Bioscience
- BDD Pharma
- Beijing InnoCare Pharma
- Beijing Tianshi Tongda Pharmaceuticals Technology
- Beijing Tide Pharmaceutical
- Belharra Therapeutics
- Belle.ai
- BenevolentAI
- Bennu Pharmaceuticals
- Beyondspring Pharmaceuticals
- BGI
- Bigfoot Biomedical
- Bill and Melinda Gates Foundation
- BinnoPharm
- Bio-Cancer Treatment International
- Bio-Gate
- Bio-Path
- Bio-Rad Laboratories
- Bio-Techne
- Bio-Thera Solutions
- bioAffinity Technologies
- biOasis Technologies
- BioClinica
- Biocon
- Biodexa Pharmaceuticals
- Biofourmis
- Biogen
- Biohaven Pharmaceuticals
- Biolojic Design
- BiomeBank
- BioMed X Innovation Center
- Biomica
- BiomX
- BiondVax
- BioNova Pharmaceuticals
- BioNxt Solutions
- Bioprojet
- Bioqube Ventures
- BioRap Technologies
- BioSenic
- BioSense Global
- Biosion
- Bird Foundation
- Blue Cross Blue Shield Association
- BlueRock Therapeutics
- Blue Shield of California
- Boehringer Ingelheim
- Boragen
- Bora Pharmaceuticals
- Boston Pharmaceuticals
- Boston University School of Medicine
- Brain Canada
- Brainomix
- BrainStorm Cell Therapeutics
- Brand Institute
- Breakthrough Health
- Brickell Biotech
- Bridge Biotherapeutics
- Brigham and Women's Hospital
- BrightInsight
- Bristol-Myers Squibb
- British Lung Foundation
- Brown University
- C4X Discovery
- Cabaletta Bio
- Cadila Pharmaceuticals
- Caladrius Biosciences
- California Institute for Biomedical Research
- California Institute for Regenerative Medicine
- California Institute of Technology
- Calliditas Therapeutics
- Calypso Biotech
- Camargo Pharmaceutical Services
- Cambridge Enterprise
- Cam Med
- Can-Fite BioPharma
- Candid Therapeutics
- Cannassure Therapeutics
- Cantargia
- Cara Therapeutics
- CareFirst BlueCross BlueShield
- Caring Cross
- Carisma Therapeutics
- Carna BioSciences
- Carnegie Mellon University
- Cartesian Therapeutics
- Casebia Therapeutics
- CASI Pharmaceuticals
- Cassie + Friends
- Castle Biosciences
- Catalyst Pharmaceuticals
- Catholic University Leuven
- CDR-Life
- Cedars-Sinai Medical Center
- Celgene
- Celiac Disease Foundation
- Cellares
- Cellerys
- Cellinfinity Bio
- Celltrion
- Celmatix
- Cel Sci
- Celsius Therapeutics
- Center for Genomic Regulation
- Centessa Pharmaceuticals
- Centre for Drug Research and Development (CDRD)
- Centurion
- Century Therapeutics
- Changchun High & New Technology Industries
- Charite-Universitatsmedizin
- Charite Universitatsmedizin Berlin
- Charles River Laboratories
- CheckPoint Immunology
- Chelexa Biosciences
- Chiesi Farmaceutici
- Children's Hospital Boston
- China Medical System
- Chinese University of Hong Kong
- Chugai Pharmaceutical
- CHU Sainte-Justine
- Cicero Diagnostics
- Cincinnati Children’s Hospital Medical Center
- Cipla
- Circassia
- Citrine Medicine
- City of Hope
- Clearside Biomedical
- Clene Nanomedicine
- Cleveland Clinic
- ClinConnect
- Clinical Enterprise
- Clinical Ink
- Clinigen
- CMS Aesthetics
- CMS Medical
- Cochin Hospital
- Coeptis Therapeutics
- Coherus Biosciences
- Collplant
- Colonoscopy Clinic
- Columbia University
- Conduit Pharmaceuticals
- ConSynance Therapeutics
- Contineum Therapeutics
- Convelo Therapeutics
- Cook Biotech
- COPD Foundation
- Corbin Therapeutics
- Corbus Pharmaceuticals
- Cornell University
- Corrona
- Cosmofix
- COUR Pharmaceutical
- COUR Pharmaceuticals
- Coya Therapeutics
- Creative Medical Technologies
- CRISPR Therapeutics
- Critical Path Institute (C-Path)
- Crohn's and Colitis Foundation of America
- CR Pharma
- CRS Bio
- Cryostem
- CrystalGenomics
- CSL Behring
- CSPC Pharmaceutical Group
- CS Pharmaceuticals
- Cue Biopharma
- Cugene
- Cullinan Therapeutics
- Cumberland Pharmaceuticals
- Curable
- Curant Health
- Cynata Therapeutics
- Cyrus Biotechnology
- Cytocom
- CytoReason
- Cyxone
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dalriada Drug Discovery
- Dalton Pharma Services
- Danuo Science Group
- DayTwo
- Debiopharm
- Decode Health
- Defymed
- Delphi Genetics
- Delta 4
- Denali Therapeutics
- Department of Defense
- Dermavant Sciences
- Dermira
- DermTech
- DevPro Biopharma
- DexCom
- Diabeloop
- Diabetes Research Connection
- Diabetes Research Institute
- Diamyd Medical
- Diomics
- Diurnal
- Diversigen
- DNAnexus
- Dong-A ST
- Dr. Falk Pharma
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- Draper Laboratories
- DreaMed Diabetes
- Dren Bio
- Duke Clinical Research Institute (DCRI)
- Duke University
- DyDo Pharma
- DynamiCure Biotechnology
- EA Pharma
- Earendil Labs
- Editas Medicine
- EffRx Pharmaceuticals
- EGeen
- Eisai
- Eisai Inc
- Eledon Pharmaceuticals
- ElevateBio
- Eleven Biotherapeutics
- Eli Lilly
- Elix
- ElsaLys Biotech
- Emendo Biotherapeutics
- Empirico
- Emulate
- Enable Biosciences
- Encore Dermatology
- Endo International
- Engitix
- Enlaza Therapeutics
- Enosi Therapeutics
- Ensho Therapeutics
- Entera Health
- Enteris Biopharma
- Enterome Bioscience
- Entos Pharmaceuticals
- Enzene Biosciences
- EOFlow
- Epicore Biosystems
- EpimAb Biotherapeutics
- epitoMAP
- Epivax
- Equillium
- Erasmus University Medical Center
- Eterna Therapeutics
- Ethos Research & Development
- Ethypharm
- EVA Pharma
- Evelo Biosciences
- Everest Medicines
- Evidation Health
- Evive Biotechnology
- Evogene
- Evolve BioSystems
- Evommune
- EVOQ Therapeutics
- Evotec
- Ewopharma
- Exagen Diagnostics
- Excelra
- Exicure
- Experimental Therapeutics Centre of Singapore
- Exscientia
- EyePoint Pharmaceuticals
- Factor Bioscience
- FairJourney Biologics
- Fast Forward
- Federal Ministry of Health (Germany)
- Feinstein Institute for Medical Research
- Ferring Pharmaceuticals
- Fibrogen
- Finch Therapeutics
- Find Therapeutics
- Fission Labs LATAM
- Flagship Pioneering
- Fluidigm
- Food and Drug Administration (FDA)
- Foresee Pharmaceuticals
- Formation Bio
- Forward Pharma
- Fosun Pharmaceutical
- Fosun Wanbang
- Foundation for Celiac Disease Outcome Measures
- Foundation for Sarcoidosis Research
- Four H
- Fred Hutchinson Cancer Research Center
- French National Institute for Agricultural Research
- Frequency Therapeutics
- Fresenius Kabi Pharmaceuticals
- FSD Pharma
- Fujifilm
- FUJIFILM Cellular Dynamics
- Fujifilm Diosynth Biotechnologies
- Fujifilm Kyowa Kirin Biologics
- Fuji Pharma
- Fundacion Progreso y Salud
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- FutureGen Biopharm
- G42 Healthcare
- Galapagos
- Galderma
- GC Biopharma
- Gedeon Richter
- GenEdit
- Genentech
- Geneoscopy
- Generex Biotechnology
- Genetic Analysis
- Genmab
- Genomics
- Genovis
- Genprex
- Genrix Bio
- Gensci
- GenScript ProBio
- Genten Therapeutics
- GentiBio
- Genzyme
- Georgetown University
- George Washington University
- Georgiamune
- Georgia State University
- Giiant Pharma
- Gilead Sciences
- Ginkgo BioWorks
- GI Reviewers
- Glenmark Pharmaceuticals
- GoodRx
- Gossamer Bio
- GPCR Therapeutics
- Graviton Bioscience
- Green Park Collaborative
- Greenstone Biosciences
- GRI Bio
- GSK
- Guangzhou Institute of Respiratory Disease
- Gusto Global
- Gynica
- Hadasit Bioholdings
- Hadassah Medical Center
- Haisco Pharmaceutical
- Halozyme Therapeutics
- HanAll Pharmaceuticals
- HanchorBio
- Hangzhou Highlightll Pharmaceutical
- Hangzhou Zhongmei Huadong Pharmaceutical
- Hannover Medical School
- Hansa Biopharma
- Haplogen
- Happify Health
- HAPPYneuron
- Harbour Biomed
- Harmony Biosciences
- Harvard Stem Cell Institute
- Harvard University
- Harvest Capital Strategies
- HCmed Innovations
- HealthPrize Technologies
- Hebei Senlang Biotechnology
- Helius Medical Technologies
- Henlius Biotech
- Hepion Pharmaceuticals
- Hesperos
- HIBio
- HiFiBio
- Highland Therapeutics
- Highmark Health
- Hikma Pharmaceuticals
- Hinge Bio
- Hoffmann La Roche
- Honeywell
- Hope Medicine
- Horizon Pharma plc
- Horizon Therapeutics
- Hospital for Special Surgery
- Hoth Therapeutics
- HotSpot Therapeutics
- Huadong Medicine
- Hudson Institute of Medical Research
- Humacyte
- Humanetics
- Humanigen
- I-mab
- IASO Biotherapeutics
- IBM
- Icahn School of Medicine at Mount Sinai
- Ichnos Sciences
- Iconovo
- Idorsia
- IFM Therapeutics
- IGM Biosciences
- Illumina
- ILTOO Pharma
- ImaginAb
- Imagine Pharmaceuticals
- Imbio
- Imcyse
- Imeka
- IMIDomics
- Immetas Therapeutics
- ImmPACT Bio
- Immugenyx
- Immunai
- ImmunArray
- ImmuneID
- Immune Pharmaceuticals
- Immune Therapeutics
- ImmuNext
- Immunic
- Immunitas Therapeutics
- ImmunoAdoptive Cell Therapy
- ImmunogenX
- Immunomic Therapeutics
- Immunovia
- Immuthera
- Inception Sciences
- Incyte
- InDex Pharmaceuticals
- Indiana University
- InduPro Therapeutics
- Industrial Technology Research Institute
- Inexia
- Infinimmune
- Inmagene Biopharmaceuticals
- Innate Pharma
- Innodem Neurosciences
- Innovate Biopharmaceuticals
- Innovate UK
- Innovation Pharmaceuticals
- Innovative Health Diagnostics
- Innovent Biologics
- Inotrem
- Inovalon
- Inserm Transfert
- InSilicoTrials
- Insmed Inc
- Institute for Genome Statistics and Bioinformatics
- Institute of Endocrinology
- Metabolism
- and Reproduction
- Institute of Human Genetics
- Institut Gustave Roussy
- Instituto de Ciencias Farmaceuticas
- Institut Pasteur
- Intas Pharmaceuticals
- Integral Molecular
- Integrated Gut Health
- Intellia Therapeutics
- Intract Pharma
- Intrexon
- Inventiva
- Iolyx Therapeutics
- Ionis Pharmaceuticals
- IONTAS
- IQVIA
- Ironwood Pharmaceuticals
- ISD Immunotech
- Italian Multiple Sclerosis Society
- Iterative Scopes
- iTolerance
- Izana Bioscience
- Jackson Laboratory
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Janssen Sciences
- Japan Tobacco
- Jazz Pharmaceuticals
- Jiangsu Hansoh Pharmaceutical
- Jiangsu Hengrui Medicine
- Jiangsu QYuns Therapeutics
- Jikei University
- Johns Hopkins Medicine (JHM)
- Johns Hopkins University
- Johnson & Johnson
- Johnson & Johnson Consumer Companies
- Johnson & Johnson Innovation
- Jolt Health
- JSR
- Jubilant Radiopharma
- Jubilant Therapeutics
- Junshi Biosciences
- Juntendo University
- Jupiter Wellness
- Juvenile Diabetes Research Foundation
- JW Pharmaceutical
- JW Therapeutics
- Kadimastem
- Kadmon Pharmaceuticals
- Kaigene
- Kaken Pharmaceutical
- Kaleido Biosciences
- Kali Therapeutics
- Kamada
- KangWon University Institute of Medical Science
- Karolinska Institute
- KBI BioPharma
- Keck School of Medicine of USC
- Keio Gijuku University
- Kelun-Biotech Biopharmaceutical
- Kenneth Rainin Foundation (KRF)
- KeyCare
- Kezar Life Sciences
- Kindeva Drug Delivery
- King's College Hospital
- Kiniksa Pharmaceuticals
- Kissei Pharmaceutical
- Kite Pharma
- Klue
- Komodo Health
- Koneksa Health
- Koye Pharmaceuticals
- Kubota Vision
- KYE Pharmaceuticals
- Kyorin Pharmaceutical
- Kyowa Hakko Kirin
- kyron.bio
- Kyverna Therapeutics
- Laboratoires Thea
- Lahey Hospital & Medical Center
- La Jolla Institute for Allergy & Immunology
- Landos Biopharma
- Lassen Therapeutics
- Laurel Venture Capital
- Leiden University
- Leona M and Harry B Helmsley Charitable Trust
- LEO Pharma
- Les Laboratoires Servier
- Lexicon Pharmaceuticals
- LGC
- LianBio
- Libbs Farmaceutica
- LifeArc
- Ligand Pharmaceuticals
- Lipidor
- LMU University Hospital Munich
- London School of Medicine and Dentistry
- Lonza
- Lubeck Institute of Experimental Dermatology
- Lucid Psycheceuticals
- Lumicera Health Services
- Luminary Therapeutics
- Lumir Lab
- Lung Biotechnology
- Lupin
- Lupus Canada
- Lupus Foundation of America (LFA)
- Lupus Research Alliance
- Lupus Therapeutics
- Lurie Children's Hospital of Chicago
- Lyfebulb
- LyGenesis
- Lynk Pharmaceuticals
- MaaT Pharma
- Mabwell Bioscience
- mAbXience
- Makana Therapeutics
- Mallinckrodt Pharmaceuticals
- Mapi Pharma
- Marengo Therapeutics
- Marinomed Biotechnologie
- Marpai
- Maruho
- Massachusetts Eye and Ear Infirmary
- Massachusetts General Hospital
- Mass General Brigham
- Max-Planck
- Max Biopharma
- Maxcyte
- Maxion Therapeutics
- Mayo Clinic
- MC2 Therapeutics
- MC10
- McGill University
- McMaster University
- MD Anderson Cancer Center
- MDNA Life Sciences
- Medac
- Medexus Pharmaceuticals
- Medgenics
- Mediar Therapeutics
- Medical International Research
- Medical University of Graz
- Medical University of South Carolina
- Medical University of Vienna
- Medical University South Carolina
- Medicines Discovery Catapult
- Medimetriks
- MedImmune
- Medison Pharma
- MedRhythms
- Medsenic
- Meiji Seika
- Melior Pharmaceuticals
- Menarini
- Menarini Asia-Pacific
- Merck and Co
- Metaba
- Metabolon
- Metrion Biosciences
- Microba Life Sciences
- Microbio Shanghai
- Microbiotica
- Microdrop
- Mimetas
- MiNA Therapeutics
- MiNK Therapeutics
- MiTest Health
- Mitsubishi Tanabe Pharma
- Moderna
- Molecular Stethoscope
- Molnlycke Health Care
- Momenta Pharmaceuticals
- Monash University
- Monte Rosa Therapeutics
- MoonLake Immunotherapeutics
- Morphic Therapeutic
- MorphoSys
- Mor Research Applications
- Mount Sinai Medical Center
- Multiple Sclerosis Society of Canada
- Mundipharma
- Mylan Laboratories
- Mylan Pharmaceuticals
- Myovant Sciences
- Myriad Genetics
- Nanjing Leads Biolabs
- NanoString Technologies
- Napo Pharmaceuticals
- National Eczema Association
- National Health Service
- National Heart
- Lung and Blood Institute
- National Institute for Environmental Health Sciences
- National Institute for Health and Care Research Respiratory Translational Research Collaboration
- National Institute of Allergy and Infectious Diseases
- National Institute of Arthritis and Musculoskeletal Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institutes of Health
- National Kidney Foundation
- National Organization for Rare Disorders
- National Psoriasis Foundation
- National Resilience
- National Science Foundation
- Navidea Biopharmaceuticals
- Navitas
- Nektar Therapeutics
- Neogap Therapeutics
- Neolaia Bio
- Neoteryx
- Neovacs
- Neovii Pharmaceuticals
- Nestle Health Science
- Neuraxpharm
- Neurodon
- NeuroGenesis
- New Day Diagnostics
- Nexel
- Nexilico
- Neximmune
- Nima
- Nimbus Therapeutics
- Ningbo Tai Kang Medical Technology
- Nippon Shinyaku
- Nipro Corporation
- Nitto Denko
- Nkarta Therapeutics
- NLS Pharmaceutics
- Nona Biosciences
- Nordic Pharma Group
- North Carolina State University
- Northway Biotechpharma
- Northwestern University
- NorthX Biologics
- North Zealand University Hospital
- Novartis
- Novartis Pharmaceuticals Canada
- Novome Biotechnologies
- Novo Nordisk
- Nuance Pharma
- Nuevolution
- Numab
- Numares
- NuMedii
- Nurix Therapeutics
- Nutra Pharma
- NuvoAir
- Nxera Pharma
- NYU Langone Medical Center
- Oak Hill Bio
- Ocumension Therapeutics
- Odyssey Therapeutics
- Oklahoma Medical Research Foundation
- OliX Pharmaceuticals
- OMass Therapeutics
- Oncocross
- One GI
- Oneness Biotech
- Ono Pharmaceutical
- Optimeos Life Sciences
- Or-Genix Therapeutics
- Orange Grove Bio
- Orexia Therapeutics
- Organon
- Orion
- Oruka Therapeutics
- OSE Immunotherapeutics
- Oslo University Hospital
- Ospedale San Raffaele
- Ossium Health
- Otsuka
- Ouro Medicines
- Ovation
- OWC Pharmaceutical Research
- Owlstone Medical
- Oxford Biomedica Solutions
- Paladin Labs
- Palisade Bio
- Palleon Pharmaceuticals
- Panaxia
- Pancryos
- Pandion Therapeutics
- Panorama Research
- Pantherna Therapeutics
- Paragon Bioservices
- ParcelShield
- Parexel
- Parexel Biotech
- Parvus Therapeutics
- Patara Pharma
- PathoQuest
- Patient-Centered Outcomes Research Institute
- PEAR Therapeutics
- Pediatric Dermatology Research Alliance
- Pediatrix Therapeutics
- Pelle Ventures
- Penn State College of Medicine
- Pfizer
- Pharmanovia
- Pharmapark
- PhaseV
- Phebra
- Pheno Therapeutics
- Philips
- Photys Therapeutics
- PicnicHealth
- Pictor
- Pioneering Medicines
- PlantEXT
- Pluristem Therapeutics
- Pluristyx
- Polpharma
- Polpharma Biologics
- Polymed Biopharmaceuticals
- Popit
- Portal Instruments
- PPD
- Pragma Bio
- Precision BioSciences
- Precision Image Analysis
- PredictImmune
- Pregene Biopharma
- Prime Therapeutics
- Principia Biopharma
- Priovant Therapeutics
- PRISM BioLab
- ProBioGen
- Procyon Technologies
- Progenity
- Progentec Diagnostics
- Prometheus Biosciences
- Prometheus Laboratories
- Promius Pharma
- Propeller Health
- ProQR Therapeutics
- Protagen
- Protagonist Therapeutics
- Protalix BioTherapeutics
- Protxx
- Provention Bio
- Provider Network of America
- Pulmonary Fibrosis Foundation (PFF)
- Purdue Pharma
- Purnovate
- PvP Biologics
- Q32 Bio
- Quadri Pharmaceuticals
- Qu Biologics
- Queen Mary University of London
- Queensland Institute of Medical Research (QIMR)
- Queensland University of Technology
- Quell Therapeutics
- Quest Diagnostics
- Quoin Pharmaceuticals
- Quotient
- Quotient Clinical
- Quotient Therapeutics
- Rafa Pharmaceuticals
- Ramot at Tel Aviv University
- Rani Therapeutics
- Recipharm
- RedHill Biopharma
- Redx Pharma
- Regen BioPharma
- Regeneron Genetics Center
- Regeneron Pharmaceuticals
- Regentys
- Regranion
- Relation Therapeutics
- Relife
- Remedium Bio
- RemeGen
- Remission Medical
- Renovion
- Repertoire Immune Medicines
- ReproCell
- Reset Therapeutics
- Resilia Pharmaceuticals
- RespirAI Medical
- RespireRx Pharmaceuticals
- Revive Therapeutics
- Revolo Biotherapeutics
- Revon Systems
- ReWalk Robotics
- Rheos Medicines
- Rigel Pharmaceuticals
- RION
- Rochal Industries
- Roche
- Roivant Sciences
- Royal College of Surgeons (Ireland)
- Royalty Pharma
- RS BioTherapeutics
- RTW Investments
- Rubedo Life Sciences
- SAB Biotherapeutics
- Sail Biomedicines
- Salix Pharmaceuticals
- Samsung Bioepis
- Samumed
- Sandoz
- Sanguine
- Sanofi
- Sanofi US Services
- Sano Genetics
- Sanpellegrino Cosmetics
- SarcoMed USA
- Sarepta Therapeutics
- Satisfai Health
- SATT Conectus Alsace
- SATT Lutech
- Savana
- Scailyte
- Schneider Children's Medical Center
- Scholar Rock
- Schrodinger
- SciBase
- SciCann Therapeutics
- Science 37
- Scipher Medicine
- Scleroderma Research Foundation
- Seattle Children's Hospital
- Seattle Childrens Research Institute
- Secarna Pharmaceuticals
- Second Genome
- Sedec Therapeutics
- Seelos Therapeutics
- Selecta Biosciences
- Selexis
- Semma Therapeutics
- Sengenics
- Senseonics
- Seres Therapeutics
- Sernova
- Serosep
- SFC Fluidics
- Shaperon
- Sheba Medical Center
- Shepherd Center
- Shire Laboratories
- Shire Pharmaceuticals
- SHL Medical
- Siemens Healthineers
- Sigilon Therapeutics
- Signum Biosciences
- Silence Therapeutics
- Simcere Pharmaceutical
- Simcere Zaiming
- Sino Biopharm
- Sino Biopharmaceutical
- Sinorda Biomedicine
- Siolta Therapeutics
- Sirion Biotech
- Sitryx
- Skyhawk Therapeutics
- Societal CDMO
- SomaLogic
- Sonde Health
- Sonoma BioTherapeutics
- Sonora Quest Laboratories
- Sorrento Therapeutics
- Sosei Heptares
- Sourcia
- Sparrow Pharmaceuticals
- Spesana
- Spiral Therapeutics
- Spring Bank Pharmaceuticals
- SQI Diagnostics
- STADA Arzneimittel
- Standigm
- Stanford University
- Stanford University School of Medicine
- Statera Biopharma
- Stoked Bio
- Stony Brook University
- Strados Labs
- Strainprint Technologies
- Strand Life Sciences
- Structural Genomics Consortium
- Sumitomo Pharmaceuticals
- Sunovion Pharmaceuticals
- Sun Pharmaceutical
- SUNY Upstate Medical University
- Surrozen
- Suzhou Connect Biopharmaceuticals
- Suzhou Intragrand Pharma
- Suzhou Porton Advanced Solutions
- Symbiotix Biotherapies
- SynAct Pharma
- Synaptogenix
- Syndax Pharmaceuticals
- Syneron Bio
- Synlogic
- Syntax Bio
- Synthekine
- Synthon
- Synthonics
- Systems Oncology
- Taiho
- Taisho Pharmaceutical
- Takara Bio
- Takeda Pharmaceutical
- TARGET PharmaSolutions
- Tavotek Biotherapeutics
- TCGFB
- Tel Aviv Sourasky Medical Center
- Temedica
- Tempest Therapeutics
- Tetragenetics
- Teva Pharmaceutical Industries
- Teva Pharmaceuticals USA
- Texas A&M University
- TFF Pharmaceuticals
- TG Therapeutics
- Tharimmune
- The Alfred Hospital
- The Consortium of Rheumatology Researchers of North America
- The Crohn's and Colitis Foundation of Canada
- The Multiple Sclerosis Association of America
- Theradiag
- Theramex
- Theravance
- The Vancouver Island Health Authority
- Three Lakes Foundation
- Thunderbolt Pharma
- TiGenix
- Tissium
- TiumBio
- Tivic Health Systems
- Tiziana Life Sciences
- TONIX Pharmaceuticals
- Topas Therapeutics
- toSense
- Tow Foundation
- Transpire
- Transpire Bio
- Travere Therapeutics
- TreeFrog Therapeutics
- Trethera
- Trinity Biotech
- True Diagnostics
- True North Therapeutics
- Truveta
- TScan Therapeutics
- Tsinghua University
- Tufts Medical Center
- Tuteur
- Twist Bioscience
- twoXAR
- TxCell
- uBriGene Biosciences
- UCB
- UGA Biopharma
- UNION Therapeutics
- United Therapeutics
- Universite Laval
- University Gastroenterology
- University Gottingen
- University Health Network
- University Hospital of Leuven
- University Hospitals Accountable Care Organization
- University Libre of Brussels
- University of Adelaide
- University of Alberta
- University of Barcelona
- University of Birmingham
- University of Bonn
- University of British Columbia
- University of Buffalo
- University of Calgary
- University of California
- San Diego
- University of California Berkeley
- University of California Irvine
- University of California San Francisco
- University of Chicago
- University of Cincinnati
- University of Colorado
- University of Connecticut
- University of Erlangen
- University of Florida
- University of Houston
- University of Illinois
- University of Manitoba
- University of Maryland
- University of Massachusetts
- University of Miami
- University of Michigan
- University of Minnesota
- University of North Carolina
- University of North Texas Health Science Center
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Queensland
- University of Sheffield
- University of Sherbrooke
- University of South Australia
- University of Texas at El Paso
- University of Texas Southwestern Medical Center
- University of Toronto
- University of Utah
- University of Virginia
- University of Washington
- University of Western Ontario
- University of Windsor
- University of Wisconsin-Madison
- University of Zurich
- Unravel Biosciences
- Upsher-Smith
- US Army Medical Research Institute of Chemical Defense
- Utrecht University
- Vaccinex
- Valeant Pharmaceuticals
- Valo Health
- Vanda Pharmaceuticals
- Vanderbilt University
- Variant Bio
- Vasomune Therapeutics
- Vcell Healthcare
- V ClinBio
- Vectura
- Vedanta Biosciences
- Velocity Pharmaceutical Development
- Veracyte
- Veraxa Biotech
- Verily
- Verona Pharma
- Versant Ventures
- Vertex Pharmaceuticals
- Vestibular Disorders Association
- ViaCyte
- Viatris
- Vicore Pharma
- Victoria University
- Viela Bio
- Vifor-Fresenius Medical Care Renal Pharma
- Vignette Bio
- Viome
- Virgo Surgical Video Solutions
- Viridian Therapeutics
- Visterra
- Vitalli Bio
- Vital Therapies
- Vivtex
- VolitionRX
- Vor Bio
- Voronoi
- Voyager Therapeutics
- vTv Therapeutics
- Wanchunbulin
- Weill Cornell Medical College
- WellDyne
- Werfen Group
- Western University
- WestGene Biopharma
- White Rock Capital Partners
- William Harvey Research Instutute
- Windward Bio
- W L Gore
- WorldCare Clinical
- Worldwide Clinical Trials
- Wuhan Kindstar Diagnostics
- WuXi Advanced Therapies
- WuXi Biologics
- Wyss Institute
- Xbrane Biopharma
- Xencor
- XL-Protein
- XtalPi
- XWPharma
- Xycrobe Therapeutics
- Xylyx Bio
- Yale School of Medicine
- Yale University
- Yangtze River Pharmaceutical Group
- Yarrow Bioscience
- Zag Bio
- ZappRx
- Zedira
- Zenas BioPharma
- Zenoaq
- Zentiva
- Zenyaku Kogyo
- Zura Bio
- Zydus Lifesciences
- Zylo Therapeutics
- Zymeworks
- ZyVersa Therapeutics
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
